These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6949614)

  • 21. In vitro drug sensitivity of leukemic progenitors and P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome.
    Basara N; Radosević-Radojković N; Colović M; Bosković D; Rolović Z
    Eur J Haematol; 1995 Aug; 55(2):83-7. PubMed ID: 7628594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
    Curtis JE; Minkin S; Minden MD; McCulloch EA
    Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adriamycin and cytosine arabinoside contribute equally to prediction of response in acute myelocytic leukemia with improved confidence level.
    Lihou MG; Smith PJ
    Cancer Chemother Pharmacol; 1985; 14(2):116-9. PubMed ID: 3855705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
    Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of blast self-renewal capacity in acute myelocytic-leukemia.
    Nara N
    Int J Oncol; 1993 Aug; 3(2):365-8. PubMed ID: 21573375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.
    Buick RN; Minden MD; McCulloch EA
    Blood; 1979 Jul; 54(1):95-104. PubMed ID: 286609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-renewal capacity of leukemic blast progenitor cells.
    Buick RN; Chang LJ; Messner HA; Curtis JE; McCulloch EA
    Cancer Res; 1981 Nov; 41(11 Pt 2):4849-52. PubMed ID: 6945908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The blast cells of acute myeloblastic leukaemia.
    McCulloch EA
    Clin Haematol; 1984 Jun; 13(2):503-15. PubMed ID: 6380855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia.
    Wang YF; Kelleher CA; Minkin S; McCulloch EA
    Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
    Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to hydrocortisone of blast progenitors in acute myeloblastic leukemia: an aspect of lineage infidelity.
    Cheng GY; Curtis JE; Tritchler D; McCulloch EA
    Leuk Res; 1985; 9(12):1547-57. PubMed ID: 3878438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside.
    Rayappa C; McCulloch EA
    Leukemia; 1993 Jul; 7(7):992-9. PubMed ID: 8321050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in acute myeloblastic leukemia.
    McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
    Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro effect of vincristine on the blast cell renewal in acute myeloblastic leukemia.
    Yamashita Y; Tohda S; Nagata K; Suzuki T; Imai Y; Nara N
    Jpn J Med; 1991; 30(5):412-9. PubMed ID: 1803040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
    Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
    Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
    Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
    Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia.
    Nara N; Kurokawa H; Tanikawa S; Tomiyama J; Nagata K
    Cancer; 1994 Jan; 73(1):92-7. PubMed ID: 8275443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.